Mark your calendar for the next Cancer Immunotherapy conference, 'Cancer Immunotherapy: Bridging Basic Research and Clinical Translation', taking place January 24-27, 2027 in Breckenridge, CO, USA.

While immunotherapies have transformed cancer treatment, they only benefit from a subset of patients, with many failing to respond or quickly developing resistance. This Keystone Symposia will examine the limitations of immunotherapies, the reasons for failure and mechanisms of resistance, to guide strategies to overcome these hurdles and improve clinical outcomes.  

Sessions will highlight emerging research on targeting stromal and myeloid cells, tumor recognition by lymphoid lineages, and advanced technologies like spatial imaging and AI to understand the tumor microenvironment. By convening leading experts across academia, industry and clinical medicine to review the successes and failures of existing therapies, explore new host immune targets, and discuss the challenges and potential of combination therapies, the meeting aims to inspire collaboration and accelerate development of more effective cancer immunotherapies. 

In the video below, Dr. Jennifer Guerriero from Brigham and Women's Hospital and Dr. Thomas Marron from the Icahn School of Medicine at Mt. Sinai, talk about what to expect from this meeting and why you should attend:

Additionally, check out some of the speaker highlights: